| Mr Michael Dean Baran, MS | |
|
Harbor Regional Hospital, 915 Anderson Drive, Aberdeen, WA 98520 | |
| (360) 532-8330 | |
| Not Available |
| Full Name | Mr Michael Dean Baran |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | Harbor Regional Hospital, Aberdeen, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568223642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00002945 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Dean Baran, MS 710 Se Crescent Dr, Shelton, WA 98584-8665 Ph: (360) 915-4338 | Mr Michael Dean Baran, MS Harbor Regional Hospital, 915 Anderson Drive, Aberdeen, WA 98520 Ph: (360) 532-8330 |
News Archive
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
In Colorado, "Gov. Bill Ritter signed four bills he promised will rein in skyrocketing health care costs on Tuesday and appointed a director who will oversee 10 state agencies to implement the Obama administration's new health care plan.
Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called "soil and seed" theory of 1889. New details that could help shed light on this hypothesis have been provided by a team of researchers from Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, and their collaborators, proposing a new mechanism controlling cancer metastasis that offers fresh diagnostic and treatment potential.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.
Blue Cross and Blue Shield of Georgia is taking an innovative approach to helping its consumers who have been diagnosed with Type 2 diabetes manage their condition to improve their health through a new virtual diabetes clinic with a smartphone app and monitoring tools.
› Verified 4 days ago
Morgan Rhea Hebish, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1801 Bay Ave, Aberdeen, WA 98520 Phone: 360-538-8805 | |
Patricia Lynne Warnick, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-8330 | |
Chelsea Wirt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-8330 | |
Dr. Alicia Henderson, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1254 N L St, Aberdeen, WA 98520 Phone: 605-382-0023 | |
Margaret Blake, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 603-731-9430 | |
Mrs. Judith Ann Mcculloch, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1006 North H St, Speech Therapy, Aberdeen, WA 98520 Phone: 360-537-6032 Fax: 360-537-6026 | |
Roberta Player, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N G St, Aberdeen, WA 98520 Phone: 360-538-2023 |